KRA-01

FDA/ORA/ORS

LIB #4578 20 of 25

Figure 16: a) Negative Control - Total Ion Chromatogram (TIC)

b) Negative Control Reconstructed Ion Chromatogram (RIC)

Kraton_27Dec12_A12 - TIC - SM: 5 RT: 5.00 - 14.99

NL: 3.65E2

RT: 11.55

10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 Relative Intensity

a

12.24

7.86

10.82

5.46

6.95

10.03

7.45

13.18

5.78

6.65

9.56

14.37

11.12

12.70

8.95

6.29

8.52

10.31

0 5

6

7

8

9

10

11

12

13

14

Time (min)

RT: 10.50 - 15.00

RT: 10.50 - 15.00

NL: 6.17E2 TIC F: + c ESI SRM ms2 399.200

11.55

NL: 3.74E2 m/z= 173.90-174.10 F: + c ESI

11.55

100

10 20 30 40 50 60 70 80 90 100

SRM ms2 399.200 [159.099-159.101, 174.099-174.101,

b

[159.099-159.101, 174.099-174.101,

95

238.199-238.201] MS Kraton_27Dec12_A12

238.199-238.201] MS Kraton_27Dec12_A12

SRM 399.2->174.1 Negative Contol Mitragynine Rt=11.53

90

Total Ion Chromatogram (TIC) Negative Contol Mitragynine Rt=11.53

85

11.12

12.32

11.71

12.70

80

10.82

11.83

14.61

75

14.56 13.50 13.99

70

10 20 30 40 50 60 70 80 90 100 Relative Abundance 0 10.82

NL: 6.17E2 TIC F: + c ESI SRM ms2 399.200 [159.099-159.101, 174.099-174.101,

12.24

11.55

65

60

238.199-238.201] MS Kraton_27Dec12_A12

11.63

55

SRM 399.2->159.1 Negative Contol Mitragynine Rt=11.53

11.63

50

13.18

11.48

12.32

45

14.89

10.82

13.89

12.04

Relative Abundance

13.98

11.51

13.73

40

13.18

11.48

35

0 10 20 30 40 50 60 70 80 90 100 0

12.32

NL: 2.52E2 m/z= 238.00-238.20 F: + c ESI

11.63

14.89

12.70

30

11.12

SRM ms2 399.200 [159.099-159.101, 174.099-174.101,

13.89

12.04

13.98

25

14.89

238.199-238.201] MS Kraton_27Dec12_A12

14.37

SRM 399.2->238.1 Negative Contol Mitragynine Rt=11.53

20

13.98

12.04

13.73

15

11.48

13.89 14.37

10

11.25

13.63

12.95

12.27

5

13.09

0

11

12

13

14

15

14

15

11

12

13

Time (min)

Time (min)

Made with